Q3 2026
Released Oct 23, 2026, before the open
10-Q filed Oct 23, 2026, 23 days after period end · 0000009326-26-000035
What the release said
On October 23, 2026, Balchem Corporation reported earnings for the quarter ended September 30, 2026, and certain other information.
Balchem reported third quarter 2026 net sales of $290.7 million, up 8.6%, and GAAP net earnings of $46.7 million, up 16.0%, from the prior year quarter.¶2¶3¶4
GAAP earnings per share were $1.46 compared to $1.24 in the prior year quarter, and adjusted earnings per share were $1.57 compared to $1.35.¶5
Balchem repurchased approximately $28 million of common stock during the third quarter and approximately $127 million over the trailing twelve months.¶6
As of September 30, 2026, the revolving loan outstanding was $124.0 million and net debt was $57.7 million, with a leverage ratio on a net debt basis of 0.2 times.¶7
- Net sales
- $290.7 million¶2
- GAAP net earnings
- $46.7 million¶2
- Adjusted EBITDA
- $80.3 million¶2
- GAAP earnings per share
- $1.46¶5
- Adjusted earnings per share
- $1.57¶5
- Free cash flow
- $57.9 million¶8
Same quarter
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $290.66M | $267.56M | $239.94M | $229.95M |
| Net Income | $46.73M | $40.29M | $33.84M | $29.08M |
| EPS Diluted | $1.46 | $1.24 | $1.03 | $0.90 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Balchem Corp · CIK 9326 · Engraved from SEC EDGAR